Home
Clinical Resources Search
PQI: Non-hormonal Birth Control Alternative with Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi®)

Non-hormonal Birth Control Alternative with Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi®)

Download PQI pdf 0.22MB

Last Updated: November 13, 2023

By: Natasha Olson, PharmD

About this PQI

The purpose of this PQI is to provide proper identification and management of patients who may benefit from the use of non-hormonal contraception using lactic acid/citric acid/potassium bitartrate (Phexxi®), a novel non-hormonal, vaginal pH modulator.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Breast Cancer Fallopian tube Ovarian

PQI

Frequently Searched

Supported by

Non-hormonal Birth Control Alternative with Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi®)

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

PQI: Ibrutinib Dosing Optimization

PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management

PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma

The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024

The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

Readiness Tracker

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Treatment Support Kit: Regorafenib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Tucatinib (Tukysa®) Management

PQI: The Role of Pharmacy in Equitable Breast Cancer Care

PQI: Stomatitis Prophylaxis During Everolimus (Afinitor®) Therapy

PQI: Sacituzumab govitecan (Trodelvy®): Management of Neutropenia and Diarrhea

PQI: Use of Rucaparib (Rubraca®) and Indications

PQI: Olaparib (Lynparza®) Expansion with Bevacizumab (Avastin®)

PQI: Mirvetuximab soravtansine-gynx (Elahere®) for Patients with Platinum-Resistant Ovarian, Fallopian tube, or Primary Peritoneal Cancer